- Home
- NVRI vs SANA Comparison
NVRI vs SANA Comparison
Compare NVRI & SANA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NVRI | SANA |
|---|---|---|
| Founded | 1853 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Diversified Commercial Services | Medicinal Chemicals and Botanical Products |
| Sector | Miscellaneous | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.4B |
| IPO Year | 1994 | 2021 |
Fundamental Metrics
Financial Performance| Metric | NVRI | SANA |
|---|---|---|
| Price | $19.16 | $3.71 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $7.80 |
| AVG Volume (30 Days) | 894.3K | ★ 3.2M |
| Earning Date | 05-14-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 17.24 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,240,358,000.00 | N/A |
| Revenue This Year | $3.87 | N/A |
| Revenue Next Year | $3.70 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $6.10 | $1.63 |
| 52 Week High | $19.99 | $6.55 |
Technical Indicators
Market Signals| Indicator | NVRI | SANA |
|---|---|---|
| Relative Strength Index (RSI) | 50.29 | 60.95 |
| Support Level | $19.14 | $3.62 |
| Resistance Level | $19.45 | $3.78 |
| Average True Range (ATR) | 0.38 | 0.28 |
| MACD | -0.06 | 0.09 |
| Stochastic Oscillator | 5.71 | 69.01 |
Price Performance
Historical ComparisonAbout NVRI Enviri Corporation
Enviri Corp is a market-leading, provider of environmental solutions for industrial and specialty waste streams, and equipment and technology for the rail sector. The company's current operations consist of three divisions: Harsco Environmental, Harsco Rail, and Clean Earth. The company gains its revenue from Harsco Environmental segment. Geographically company operates in USA and International Countries, with majority revenue from USA.
About SANA Sana Biotechnology Inc.
Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs for across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates is comprised of SC291, SC262, SC255, UP421 and others.